Kalle Jokelainen
Helsinki University Central Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kalle Jokelainen.
Life Sciences | 1997
Kalle Jokelainen; T. Nosova; T. Koivisto; S. Väkeväinen; H. Jousimies-Somer; R. Heine; M. Salaspuro
Many colonic bacteria possess marked alcohol dehydrogenase (ADH) activity and are capable of oxidizing ethanol to acetaldehyde both in vitro and in vivo. We have recently shown that part of ingested ethanol is metabolized to acetaldehyde in the colon during normal alcohol metabolism. To assess the contribution of this bacteriocolonic pathway for ethanol oxidation to total ethanol metabolism, the elimination rate of ethanol, faecal aerobic flora and faecal ADH activity were determined in rats before and after the treatment with ciprofloxacin (200 mg/kg/day) for four days. Ciprofloxacin treatment decreased ethanol elimination rate from 310+/-9 to 282+/-13 mg/kg/h (mean+/-SE; p<0.02), markedly reduced faecal aerobic flora, and also lowered faecal ADH activity from 63+/-17 to 17+/-7 nmol/min/mg faeces (p<0.05). Neither hepatic ADH nor microsomal ethanol oxidizing system activities were affected by the ciprofloxacin treatment. On the contrary, an acute intraperitoneal dose of ciprofloxacin had no effect on the rate of ethanol elimination. These results support the significant role of the bacteriocolonic pathway in total ethanol elimination, and open a new, microbiological, perspective for studies on ethanol metabolism and pathogenesis of alcohol related organ damages.
Drug and Alcohol Dependence | 1990
Päivi Kärkkäinen; Kalle Jokelainen; Risto Roine; Antti Suokas; Mikko Salaspuro
The effects of moderate alcohol intake on serum (SHEX)- and urinary beta-hexosaminidase (UHEX) were studied in ten healthy volunteers, who ingested 60 g of 100% ethanol daily for 10 days. The drinking period was preceded and followed by an abstinence period. Moderate drinking and abstinence were rapidly and significantly reflected on SHEX, while UHEX levels did not change significantly during the study. Gramma-glutamyl transpeptidase (GGT), aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) decreased during the first abstinence period (P less than 0.05), but stayed thereafter at a constant level. It is concluded that SHEX may better reflect recent alcohol consumption than UHEX, GGT, ASAT or ALAT.
Alcoholism: Clinical and Experimental Research | 2003
Sémia H. Zidi; Klas Linderborg; Satu Väkeväinen; Mikko Salaspuro; Kalle Jokelainen
BACKGROUND Normal colonic bacteria possessing alcohol dehydrogenase activity can oxidize ethanol to acetaldehyde. Acetaldehyde recently has been shown to be a local carcinogen in humans. The aim of the study was to examine the effect of lactulose feeding on fecal and cecal pH, intracolonic acetaldehyde concentration, and total ethanol elimination rate in rats. METHODS Sixty Wistar rats were divided into four groups. Groups 2 and 4 received lactulose daily (11 g/kg body weight for 14 days). On days 7 and 14, groups 1 and 2 received ethanol (1.5 g/kg body weight) intraperitoneally, whereas groups 3 and 4 received saline. RESULTS Fecal and cecal pH values decreased significantly after lactulose treatment compared with the controls. Lactulose feeding reduced the total ethanol elimination rate by 13.8% (257 +/- 0.008 mg/kg/hr vs. 298 +/- 0.003 mg/kg/hr, p < 0.001) and the intracecal acetaldehyde concentration by 66.2% after ethanol (49 +/- 29 microM vs. 145 +/- 47 microM, p = 0.03) compared with the controls. CONCLUSION Lactulose feeding to rats significantly reduces ethanol elimination rate and intraluminal acetaldehyde concentration in the colon after ethanol administration. This prebiotic thus could be used as an effective agent to block the microbial production of carcinogenic acetaldehyde in the large intestine.
Carcinogenesis | 1997
Nils Homann; Hannele Jousimies-Somer; Kalle Jokelainen; Riitta Heine; Mikko Salaspuro
American Journal of Physiology-gastrointestinal and Liver Physiology | 2003
Amin A. Nanji; Kalle Jokelainen; Gl Tipoe; Amir Rahemtulla; Peter Thomas; Andrew J. Dannenberg
Journal of the National Cancer Institute | 1997
Nils Homann; Tiina Koivisto; Tatiana Nosova; Kalle Jokelainen; Mikko Salaspuro; Päivi Kärkkäinen
American Journal of Physiology-gastrointestinal and Liver Physiology | 2001
Amin A. Nanji; Kalle Jokelainen; Maryam Fotouhinia; Amir Rahemtulla; Peter Thomas; Gl Tipoe; Grace L. Su; Andrew J. Dannenberg
Journal of Pharmacology and Experimental Therapeutics | 2004
Amin A. Nanji; Andrew J. Dannenberg; Kalle Jokelainen; Nathan M. Bass
Alcoholism: Clinical and Experimental Research | 1996
Kalle Jokelainen; A. Siitonen; Hannele Jousimies-Somer; T. Nosova; R. Heine; Mikko Salaspuro
Journal of Pharmacology and Experimental Therapeutics | 2001
Amin A. Nanji; Kalle Jokelainen; Gl Tipoe; Amir Rahemtulla; Andrew J. Dannenberg